Jarislowsky, Fraser Ltd’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.56M Sell
46,215
-25,625
-36% -$1.5M 0.01% 122
2025
Q2
$4.96M Sell
71,840
-8,533
-11% -$580K 0.03% 103
2025
Q1
$5.58M Buy
80,373
+2,932
+4% +$242K 0.04% 100
2024
Q4
$6.66M Buy
77,441
+3,944
+5% +$427K 0.04% 93
2024
Q3
$8.75M Sell
73,497
-7,860
-10% -$1.05M 0.05% 91
2024
Q2
$11.6M Sell
81,357
-37,695
-32% -$5M 0.07% 84
2024
Q1
$15.3M Sell
119,052
-4,680
-4% -$557K 0.09% 86
2023
Q4
$12.8M Sell
123,732
-9,550
-7% -$944K 0.08% 88
2023
Q3
$12.1M Sell
133,282
-2,380
-2% -$210K 0.08% 86
2023
Q2
$11M Sell
135,662
-3,600
-3% -$294K 0.07% 88
2023
Q1
$11.1M Sell
139,262
-3,930
-3% -$279K 0.07% 86
2022
Q4
$9.69M Sell
143,192
-6,500
-4% -$381K 0.06% 94
2022
Q3
$7.46M Sell
149,692
-7,120
-5% -$381K 0.05% 95
2022
Q2
$8.74M Sell
156,812
-6,750
-4% -$375K 0.06% 98
2022
Q1
$9.08M Sell
163,562
-5,350
-3% -$275K 0.05% 99
2021
Q4
$9.46M Sell
168,912
-3,900
-2% -$211K 0.04% 98
2021
Q3
$8.29M Sell
172,812
-5,030
-3% -$243K 0.04% 101
2021
Q2
$7.45M Sell
177,842
-10,650
-6% -$413K 0.03% 109
2021
Q1
$6.35M Sell
188,492
-9,350
-5% -$333K 0.03% 114
2020
Q4
$6.91M Sell
197,842
-7,000
-3% -$242K 0.04% 106
2020
Q3
$7.11M Sell
204,842
-9,550
-4% -$318K 0.04% 104
2020
Q2
$7.02M Sell
214,392
-4,350
-2% -$139K 0.04% 103
2020
Q1
$6.58M Sell
218,742
-6,430
-3% -$191K 0.05% 100
2019
Q4
$6.52M Sell
225,172
-14,554
-6% -$403K 0.03% 105
2019
Q3
$6.2M Sell
239,726
-9,950
-4% -$252K 0.03% 106
2019
Q2
$6.37M Sell
249,676
-31,850
-11% -$787K 0.04% 105
2019
Q1
$7.36M Buy
281,526
+2,900
+1% +$71.3K 0.05% 104
2018
Q4
$6.42M Sell
278,626
-3,648
-1% -$81.1K 0.04% 106
2018
Q3
$6.09M Sell
282,274
-2,488
-0.9% -$60.7K 0.04% 112
2018
Q2
$6.57M Buy
284,762
+2,736
+1% +$65K 0.04% 112
2018
Q1
$6.94M Sell
282,026
-732
-0.3% -$19.2K 0.04% 110
2017
Q4
$7.59M Sell
282,758
-11,396
-4% -$290K 0.04% 113
2017
Q3
$7.08M Sell
294,154
-8,248
-3% -$186K 0.04% 117
2017
Q2
$6.49M Buy
302,402
+9,170
+3% +$185K 0.04% 117
2017
Q1
$5.03M Buy
293,232
+6,352
+2% +$111K 0.03% 122
2016
Q4
$5.14M Buy
286,880
+5,970
+2% +$108K 0.03% 122
2016
Q3
$5.84M Buy
280,910
+1,480
+0.5% +$36.7K 0.04% 112
2016
Q2
$7.51M Buy
279,430
+11,250
+4% +$309K 0.05% 86
2016
Q1
$7.27M Sell
268,180
-3,830
-1% -$103K 0.05% 109
2015
Q4
$7.9M Buy
272,010
+3,100
+1% +$85.8K 0.06% 108
2015
Q3
$7.29M Buy
268,910
+6,930
+3% +$196K 0.05% 106
2015
Q2
$7.17M Sell
261,980
-3,050
-1% -$85.7K 0.05% 105
2015
Q1
$7.07M Sell
265,030
-2,470
-0.9% -$56.9K 0.05% 106
2014
Q4
$5.66M Sell
267,500
-6,500
-2% -$145K 0.04% 109
2014
Q3
$6.52M Sell
274,000
-4,700
-2% -$108K 0.04% 104
2014
Q2
$6.44M Sell
278,700
-550
-0.2% -$12.1K 0.04% 102
2014
Q1
$6.37M Sell
279,250
-6,700
-2% -$143K 0.04% 104
2013
Q4
$5.28M Sell
285,950
-53,900
-16% -$939K 0.03% 105
2013
Q3
$5.75M Sell
339,850
-17,600
-5% -$296K 0.03% 103
2013
Q2
$5.54M Buy
+357,450
New +$5.95M 0.03% 99

Other funds holding NVO